Reading Peptide References Without Overstating Findings

Section

Study Design First

The model, sample preparation, controls, and measured endpoint should be reviewed before interpreting a study summary. A finding in one model may not transfer to another system.

Section

Separate Observation From Conclusion

A measured marker or pathway association should be described as an observation unless the source supports a stronger interpretation. Neutral summaries reduce the risk of overstating the literature.

Section

Use Plain Limits

Where evidence is preliminary, model-specific, or based on narrow conditions, the limitation should be visible in the summary rather than hidden in technical wording.

References